Header Logo

Connection

Kathleen Moore to Immunotherapy

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Immunotherapy.
Kathleen Moore
Connection Strength
0.034
Immunotherapy
  1. Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer. Cancer Lett. 2018 07 01; 425:174-182.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.